Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect of DHP107 (Oral Paclitaxel) in Advanced Solid Tumors
NCT04675528Phase 1Completed
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Start
- May 2021
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of paclitaxel oral solution in solid tumor (2 arms), sponsored by Daehwa Pharmaceutical Co., Ltd. Primary endpoints: Maximum Plasma Concentration at Day 8 and Time to Maximum Plasma Concentration at Day 8. Started May 2021; status: completed.
02
Drugs
paclitaxel oral solution
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04675528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04675528.